Showing 1191-1200 of 9130 results for "".
Skin Cancer Awareness, Epiduo Data, Impoyz Launch
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-skin-cancer-awareness-epiduo-data-impoyz-launch/18307/Data shed light on patents' attitudes towards kids' sunblock and new findings emerge on melanoma risks. FDA accepts BLA for cemiplimab for advanced SCC and approves Novartis' Tafinlar in combination with Mekinist for the adjuvant treatment of patients with melanoma with BRAF V600E or V600K mutationsSkin Cancer Prevention, Mohs Data, Allergan Closes on Zeltiq
https://practicaldermatology.com/topics/practice-management/dermwiretv-skin-cancer-prevention-mohs-data-allergan-closes-on-zeltiq/18479/It's Skin Cancer Awareness Month. Joel L. Cohen, MD and Shadi Kourosh, MD share tips on patient education and skin protection. Plus, new data set the stage for developing best practices for Mohs micrographic surgery. Wendy Lewis offers tips for digital marketing success. Plus, Allergan closes the deWhat's your Mobile Engagement Quotient?
https://practicaldermatology.com/topics/practice-management/meq/18486/Do you know your mobile engagement quotient? Do you even know what MEQ is? To connect with and expand your patient base, you need to enhance mobile engagement. Learn what you need to know in this Ekwa.com Marketing Educational video.UV Talk: Men and Women
https://practicaldermatology.com/topics/skin-cancer-photoprotection/uv-talk-men-and-women/18695/Talk to every patient about UV avoidance, but tailor your patient to each patient's needs and behavior, says Joel L. Cohen, MD. Consider the patient's sex when making recommendations. Watch now to get Dr. Cohen's tip for endurance athletes.Online Reputation Management: Take Charge
https://practicaldermatology.com/topics/practice-management/online-reputation-management-take-charge/18601/Why is reputation management important for healthcare practices? Medical practices have an expectation to protect. Negative opinions can be shred quickly and widely, swaying patient opinion. A majority of individuals (88%) trust online reviews as much as personal recommendations, according to researWondering with Steve and Sabrina: Mexico
https://practicaldermatology.com/topics/skin-cancer-photoprotection/wondering-with-steve-and-sabrina-mexico/18646/Traveling in the Baja Desert, Steven Dayan, MD and Sabrina Fabi, MD discover the benefits of Lomboy, a plant that can be used for sun protection. While natural isn't always better (think poison ivy), Lomboy is widely used to protect the skin because it produces a thick white paste. (C) Steven Dayan,Managing Comorbidites of Psoriasis
https://practicaldermatology.com/topics/psoriasis/managing-comorbidites-of-psoriasis/18808/Ron Prussick, MD explains why it's important for dermatologists to discuss the risks of comorbidities such as cardiovascular events, fatty liver disease, depression, and more with patients with psoriasis. While it needs to be determined if the treatments used to treat the outside effects of psoriasiDriving Growth in the Dermatology Practice
https://practicaldermatology.com/topics/practice-management/driving-growth-in-the-dermatology-practice/18630/Robert Rullo reminds dermatologists to think beyond being just a clinician and to remember they are also running a business. He discusses key business philosophies clinicians need to be aware of and common obstacles that inhibit geometric practice growth. GenerationsTravelers Beware: Infectious Skin Dermatoses
https://practicaldermatology.com/topics/general-topics/travelers-beware-infectious-skin-dermatoses/18691/Theodore Rosen, MD and Natasha Mesinkovska, MD talk to Derm Insider host Neal Bhatia, MD about traveler maladies that affect the skin. Drs. Rosen and Mesinkovska run down diagnostic and treatment pearls for conditions ranging from parasitic infections to bed bug bites to emerging infections. They alPsoriasis PACT Launches with Pfizer Support
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-psoriasis-pact-launches-with-pfizer-support/19028/New Services Launched to Support Psoriasis Patients, Dermatologists; New Developments in Valeant's Bid for Allergan; Promising Results for a Topical for Hyperhidrosis